This article describes how behavioral science can be applied in cardiometabolic clinical research to augment drug interventions. This combined approach addresses the Health Inequity gap while also increasing patient engagement.
Chief Executive Officer
Chief Technology Officer
Chief Financial Officer
Chief Compliance Officer
Rare Disease Expert
Sales and SolutionsDirect 1.336.714.7402
SupportToll-Free 1.800.301.5033Direct 1.336.714.7402
Insert HTML text here.